| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S K Jain, M K Chourasia, A K Jain, R K Jain, A K Shrivastav. Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery. Drug delivery. vol 11. issue 2. 2004-07-06. PMID:15200010. |
development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery. |
2004-07-06 |
2023-08-12 |
Not clear |
| Levent Dirikolu, Brad A Mollett, Amy Troppmann, William E Woods, Calvert Bratton, Conor P Cashman, Dwight Schroedter, Brent Mayer, Andreas F Lehner, Wojciech Karpiesiuk, Charlie Hughes, Jeff Boyles, John D Harkins, Thomas Tobi. Apparent ELISA detection times for albuterol after administration with the torpex equine inhaler device. Veterinary therapeutics : research in applied veterinary medicine. vol 3. issue 3. 2003-01-10. PMID:12447838. |
testing of nasal swabs by elisa demonstrated the presence of albuterol for 8 hours after each single dose, and some horses might have detectable levels of albuterol in nasal swabs for several days following administration of multiple doses. |
2003-01-10 |
2023-08-12 |
Not clear |
| N Weksler, S Brill, A Tarnapolski, G M Gurma. Intranasal salbutamol instillation in asthma attack. The American journal of emergency medicine. vol 17. issue 7. 1999-12-28. PMID:10597090. |
we describe herein the use of nasal salbutamol in 3 patients with severe asthma attacks who were refractory to conventional therapy, with favorable responses and without significant undesirable effects. |
1999-12-28 |
2023-08-12 |
Not clear |
| T Ka. [Effects of topical alpha 1- and beta 2-adrenoceptor stimulants on nasal nitric oxide level]. Nihon Jibiinkoka Gakkai kaiho. vol 102. issue 7. 1999-11-02. PMID:10459292. |
the effects of locally administered alpha 1- and beta 2-stimulants (naphazoline and salbutamol) on the nasal nitric oxide (no) level were investigated. |
1999-11-02 |
2023-08-12 |
human |
| T Ka. [Effects of topical alpha 1- and beta 2-adrenoceptor stimulants on nasal nitric oxide level]. Nihon Jibiinkoka Gakkai kaiho. vol 102. issue 7. 1999-11-02. PMID:10459292. |
the changes in nar, mca and ncv indicated that nasal mucosa became contracted and swollen by topical naphazoline and salbutamol application. |
1999-11-02 |
2023-08-12 |
human |
| T Ka. [Effects of topical alpha 1- and beta 2-adrenoceptor stimulants on nasal nitric oxide level]. Nihon Jibiinkoka Gakkai kaiho. vol 102. issue 7. 1999-11-02. PMID:10459292. |
naphazoline, a nasal decongestant, contract nasal vessels by stimulating alpha 1-adrenoceptors, whereas salbutamol dilates then by stimulating beta 2-adrenoceptors, and this vasodilation does not intervene no and cyclic gmp. |
1999-11-02 |
2023-08-12 |
human |
| Z Fermin, D Bout, P Ricciardi-Castagnoli, J Hoebek. Salbutamol as an adjuvant for nasal vaccination. Vaccine. vol 17. issue 15-16. 1999-07-08. PMID:10217592. |
salbutamol as an adjuvant for nasal vaccination. |
1999-07-08 |
2023-08-12 |
mouse |
| Z Fermin, D Bout, P Ricciardi-Castagnoli, J Hoebek. Salbutamol as an adjuvant for nasal vaccination. Vaccine. vol 17. issue 15-16. 1999-07-08. PMID:10217592. |
salbutamol, a beta-adrenergic agonist, which transiently increases camp levels, was tested for its potential adjuvant activity in nasal vaccination. |
1999-07-08 |
2023-08-12 |
mouse |
| E W Schmid. Pharmacokinetics of beta2-sympathomimetics at the example of fenoterol and conclusion for the administration. Wiadomosci lekarskie (Warsaw, Poland : 1960). vol 51. issue 1-2. 1998-06-25. PMID:9608824. |
the pharmacokinetics of fenoterol (salbutamol, terbutaline) after systemic administration (i.v., infusion, nasal administration) can be best described by a three-compartmental model. |
1998-06-25 |
2023-08-12 |
Not clear |
| E D Allen, E R Whitaker, G Ry. Six-week trial of nebulized flunisolide nasal spray: efficacy in young children with moderately severe asthma. Pediatric pulmonology. vol 24. issue 6. 1998-02-20. PMID:9448231. |
we conclude that 1 ml (250 microg) of nebulized flunisolide nasal spray solution, administered three times daily, reduced the severity of asthma symptoms, and the need for both albuterol aerosol and systemic corticosteroid therapy in young children with moderately severe asthma during a 6-week trial. |
1998-02-20 |
2023-08-12 |
Not clear |
| S B Phagoo, R A Watson, N B Prid. Use of nasal peak flow to assess nasal patency. Allergy. vol 52. issue 9. 1997-10-30. PMID:9298174. |
in further experiments, we altered intrapulmonary airway calibre by having subjects inhale histamine or salbutamol aerosols and examined effects on the configuration of nasal flow-volume curves (six subjects with rhinitis and mild asthma). |
1997-10-30 |
2023-08-12 |
human |
| J N Baraniuk, M Ali, D Brody, J Maniscalco, E Gaumond, T Fitzgerald, G Wong, A Yuta, J C Mak, P J Barnes, R Bascom, T Troos. Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa. American journal of respiratory and critical care medicine. vol 155. issue 2. 1997-03-11. PMID:9032216. |
human nasal mucosa was cultured for 3 d with and without 1 microm dex, then challenged with media or 100 microm albuterol. |
1997-03-11 |
2023-08-12 |
human |
| J N Baraniuk, M Ali, D Brody, J Maniscalco, E Gaumond, T Fitzgerald, G Wong, A Yuta, J C Mak, P J Barnes, R Bascom, T Troos. Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa. American journal of respiratory and critical care medicine. vol 155. issue 2. 1997-03-11. PMID:9032216. |
in vivo, normal subjects received saline or bdp for 3 d before albuterol nasal provocation. |
1997-03-11 |
2023-08-12 |
human |
| D G Peckham, A Conn, C Chotai, S Lewis, A J Kno. Effect of oral digoxin, topical ouabain and salbutamol on transepithelial nasal potential difference in patients with cystic fibrosis. Clinical science (London, England : 1979). vol 89. issue 3. 1996-01-11. PMID:7493424. |
effect of oral digoxin, topical ouabain and salbutamol on transepithelial nasal potential difference in patients with cystic fibrosis. |
1996-01-11 |
2023-08-12 |
human |
| J S Lacroix, A M Kurt, S Auberson, C Bretto. Beta-adrenergic mechanisms in the nasal mucosa vascular bed. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. vol 252. issue 5. 1995-12-13. PMID:7576588. |
in thiopentone-anesthetized mature pigs (n = 7), local intra-arterial infusion of the beta 2-adrenoceptor agonists terbutaline and salbutamol and the beta 3-agonist brl 37344 induced dose-dependent increases in nasal arterial blood flow (bf) and volume of the nasal mucosa (reflecting capacitance vessel function). |
1995-12-13 |
2023-08-12 |
human |
| J S Lacroix, A M Kurt, S Auberson, C Bretto. Beta-adrenergic mechanisms in the nasal mucosa vascular bed. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. vol 252. issue 5. 1995-12-13. PMID:7576588. |
after precontraction in a krebs-ringer solution with 50 nm k+, all nasal biopsies studied showed dose-dependent relaxation to terbutaline, salbutamol and brl 37344. |
1995-12-13 |
2023-08-12 |
human |
| D N Roberts, M A Birchall, C A East, G Scaddin. Intranasal salbutamol has no effect on mucociliary clearance in normal subjects. Clinical otolaryngology and allied sciences. vol 20. issue 3. 1995-11-14. PMID:7554338. |
this double-blind placebo-controlled trial in 37 normal subjects compared topical salbutamol against placebo on nasal mucociliary clearance. |
1995-11-14 |
2023-08-12 |
human |
| D N Roberts, M A Birchall, C A East, G Scaddin. Intranasal salbutamol has no effect on mucociliary clearance in normal subjects. Clinical otolaryngology and allied sciences. vol 20. issue 3. 1995-11-14. PMID:7554338. |
the results show that topical salbutamol appears to have no effect on nasal mucociliary clearance times in vivo in normal subjects. |
1995-11-14 |
2023-08-12 |
human |
| P Mialon, R Charfi, J Regnard, A Lockhart, A T Dinh-Xua. Locally deposited but not inhaled frusemide reduces nasal potential difference in healthy subjects. European journal of clinical pharmacology. vol 45. issue 4. 1994-03-07. PMID:8299668. |
in an attempt to reconcile these observations, we have measured the effect of inhalation through the nose and local deposition of f, amiloride (a), bumetanide (b) and salbutamol (s) on nasal pd in 7 healthy male volunteers in a randomised, double blind study. |
1994-03-07 |
2023-08-12 |
human |
| E J Stewart, M J Cinnamond, P Nicholls, C F Standfor. The influence of beta-adrenoceptors on nasal mucosal function. Rhinology. vol 31. issue 3. 1994-01-11. PMID:8256080. |
neither placebo nor 100 mg salbutamol affected nasal secretion production at rest, but propranolol caused a transient significant increase (p < 0.05). |
1994-01-11 |
2023-08-12 |
human |